Vicarious

Vicarious Surgical Announces Promotion of John Mazzola to Chief Operating Officer

Retrieved on: 
Thursday, May 18, 2023

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the promotion of John Mazzola to Chief Operating Officer.

Key Points: 
  • Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the promotion of John Mazzola to Chief Operating Officer.
  • John joined Vicarious Surgical in March of 2022 as SVP of Operations and has over 35 years of medical device industry experience.
  • In the past year, John has led strategic manufacturing plans for the Vicarious Surgical robotic system, overseeing operations and quality organizations.
  • “The newly-created COO role carries great importance as we expand our near-term focus from system development toward initial manufacturing processes for our V1.0 system,” said Adam Sachs, Chief Executive Officer at Vicarious Surgical.

Vicarious Surgical Earns Recognition from Fast Company and MedTech Breakthrough Awards

Retrieved on: 
Thursday, May 4, 2023

Vicarious Surgical, Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company earned recognition from Fast Company and the MedTech Breakthrough Awards for two industry awards:

Key Points: 
  • Vicarious Surgical, Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company earned recognition from Fast Company and the MedTech Breakthrough Awards for two industry awards:
    First, Fast Company’s 2023 World Changing Ideas Awards selected Vicarious Surgical as an honorable mention.
  • Second, the MedTech Breakthrough Awards named the Vicarious Surgical robotics system the winner in its “Best Healthcare Robotics Solution” category.
  • The MedTech Breakthrough Awards is an independent market intelligence organization that recognizes the “breakthrough” companies, people, platforms and products in today’s health, fitness and medical technology industries.
  • “As a company, we have made significant strides in establishing strategic hospital system partnerships and completing our Beta 2 surgical system.

Vicarious Surgical System Named to TIME’s List of the Best Inventions of 2022

Retrieved on: 
Thursday, November 10, 2022

Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the outcomes, cost, and efficiency of surgical procedures, today announced their robotic system has been named one of TIMEs Best Inventions of 2022 .

Key Points: 
  • Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the outcomes, cost, and efficiency of surgical procedures, today announced their robotic system has been named one of TIMEs Best Inventions of 2022 .
  • The Vicarious Surgical robot was recognized in the experimental inventions category of TIMEs annual list, which features 200 extraordinary innovations changing our lives.
  • We are honored to be included on such an esteemed list alongside so many innovative companies, said Adam Sachs, CEO of Vicarious Surgical.
  • Vicarious Surgical completed its Beta 2 system design for its surgical robotic system earlier this year and will showcase the finalized Beta 2 system at its Demonstration Day for investors and analysts on Tuesday, December 6, 2022.

Vicarious Surgical Reports Third Quarter 2022 Financial Results

Retrieved on: 
Monday, November 7, 2022

Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended September 30, 2022.

Key Points: 
  • Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended September 30, 2022.
  • ET on Monday, November 7, 2022, to discuss its third quarter 2022 financial results.
  • Vicarious Surgical believes that the Non-GAAP Financial Measures enhance an investors understanding of Vicarious Surgicals financial performance as it is useful in assessing its operating performance from period-to-period by excluding certain items that Vicarious Surgical believes are not representative of its core business.
  • The Non-GAAP Financial Measures do not replace the presentation of Vicarious Surgicals U.S. GAAP financial results and should only be used as a supplement to, not as a substitute for, Vicarious Surgicals financial results presented in accordance with U.S. GAAP.

Vicarious Surgical Announces Memorandum of Understanding Agreement with Pittsburgh CREATES to Advance System Design

Retrieved on: 
Monday, November 7, 2022

Through this collaboration, Vicarious Surgical will further augment its development efforts with a world-renowned university.

Key Points: 
  • Through this collaboration, Vicarious Surgical will further augment its development efforts with a world-renowned university.
  • We look forward to the work ahead as we seek to transform the standard in surgical robotics.
  • Pittsburgh CREATES is an industry-facing, medical innovation center that fosters collaborations between surgeons, healthcare professionals, entrepreneurs, and innovators to deliver value-driven healthcare technology advances in the Pittsburgh region.
  • The Companys novel surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery.

Vicarious Surgical Announces Changes to Board of Directors

Retrieved on: 
Thursday, October 20, 2022

Vicarious Surgical Inc. (Vicarious Surgical or the Company), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the resignation of technology-focused venture capitalists Dror Berman and Samir Kaul from the Vicarious Surgical Board of Directors effective October 18, 2022.

Key Points: 
  • Vicarious Surgical Inc. (Vicarious Surgical or the Company), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the resignation of technology-focused venture capitalists Dror Berman and Samir Kaul from the Vicarious Surgical Board of Directors effective October 18, 2022.
  • The Company also announced the appointment of Beverly Huss to the Vicarious Surgical Board of Directors, effective as of the same day.
  • On behalf of the Board, I would like to thank Samir and Dror for their meaningful contributions and dedication to Vicarious Surgical over the past years; both have been instrumental in Vicarious evolution from tech start-up into the public, surgical robotic company that it is today, said David Styka, Chairman of the Vicarious Surgical Board.
  • I am honored to join the Vicarious Surgical Board at this exciting phase for the Company, said Ms. Huss.

Vicarious Surgical Reports Second Quarter 2022 Financial Results

Retrieved on: 
Monday, August 8, 2022

Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended June 30, 2022.

Key Points: 
  • Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended June 30, 2022.
  • R&D expenses for the second quarter of 2022 were $10.1 million, compared to $4.0 million in the second quarter of 2021.
  • General and administrative expenses for the second quarter of 2022 were $7.8 million, compared to $2.3 million in the second quarter of 2021.
  • ET on Monday, August 8, 2022, to discuss its second quarter 2022 financial results.

Vicarious Surgical Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes

Retrieved on: 
Tuesday, June 21, 2022

The Russell 2000 Index is the most common benchmark for small capitalization companies and the Russell Microcap Index measures the performance of the microcap segment of the U.S. equity market.

Key Points: 
  • The Russell 2000 Index is the most common benchmark for small capitalization companies and the Russell Microcap Index measures the performance of the microcap segment of the U.S. equity market.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes.
  • We are pleased to see Vicarious Surgical added to the Russell indexes following our successful listing on the New York Stock Exchange in September 2021, said Adam Sachs, Chief Executive Officer of Vicarious Surgical.
  • For more information on the Russell indexes reconstitution, go to the Russell Reconstitution section on the FTSE Russell website .

Vicarious Surgical Reports First Quarter 2022 Financial Results

Retrieved on: 
Monday, May 9, 2022

Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended March 31, 2022.

Key Points: 
  • Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended March 31, 2022.
  • ET on Monday, May 9, 2022, to discuss its first quarter 2022 financial results.
  • Vicarious Surgical believes that the Non-GAAP Financial Measures enhance an investors understanding of Vicarious Surgicals financial performance as it is useful in assessing its operating performance from period-to-period by excluding certain items that Vicarious Surgical believes are not representative of its core business.
  • The Non-GAAP Financial Measures do not replace the presentation of Vicarious Surgicals U.S. GAAP financial results and should only be used as a supplement to, not as a substitute for, Vicarious Surgicals financial results presented in accordance with U.S. GAAP.

Vicarious Surgical Appoints John Mazzola as Vice President of Operations

Retrieved on: 
Thursday, March 24, 2022

Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as the cost and efficiency of surgical procedures, today announced the appointment of John Mazzola as vice president of operations.

Key Points: 
  • Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as the cost and efficiency of surgical procedures, today announced the appointment of John Mazzola as vice president of operations.
  • Mazzola has more than 30 years of global operations and engineering management experience with leading companies in the medical device industry.
  • Before joining Vicarious, Mazzola was a vice president of operations at Becton Dickinson Surgery.
  • We are excited to welcome John to our team as our vice president of operations, said Adam Sachs, CEO and co-founder of Vicarious Surgical.